S1 Table - by Yong-Rae Kim (19797278)

Subjects:

S2 Table - by Yong-Rae Kim (19797278)

Subjects:

Participant characteristics (<i>n</i> = 34). by Yong-Rae Kim (19797278)

Subjects:

S4 Table - by Yong-Rae Kim (19797278)

Subjects:

S6 Table - by Yong-Rae Kim (19797278)

Subjects:

Spontaneous oxycodone withdrawal initially flattens NREM power rhythms, decreases low frequency and increases high frequency power. by Michael Gulledge (20577135)

Table 1_Elevated CO2 decreases micronutrient Zn but not Fe in vegetables – evidence from a meta-analysis.docx by Xiaolin Wang (303612)

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx by Xuanbo Zhou (19374205)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…Group differences were tested with general linear models.</p><p dir="ltr"><b>Results: </b>No significant differences were found between people with and without HVDs on any of the measures. …”

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

Flow chart of participants selection. by Linjia Duan (13276989)

Subjects:

Details of the GWAS data in this study. by Jing Wang (6206297)

Subjects:

Association of covariates and COPD risk. by Yushan Shi (16440272)

Subjects:

S8 File - by Martha R. Smith (20410184)

Subjects:

Study populations of included studies. by Martha R. Smith (20410184)

Subjects:

Future research directions. by Martha R. Smith (20410184)

Subjects:

PRISMA flow diagram. by Martha R. Smith (20410184)

Subjects: